Florida nurse testifies on Capitol Hill after firing over COVID care

A Central Florida nurse with 31 years at one hospital told a U.S. Senate roundtable she was fired after advocating for a COVID-19 patient and recommending a treatment the physician ordered. West Cocoa Pharmacy & Compounding praised the testimony as a stand against corporate control in healthcare.

Why it matters: - Donna Lowrey’s testimony puts a human face on the conflict between bedside judgment and institutional decision-making during the COVID-19 pandemic. - The case also highlights a broader fight for Florida’s independent pharmacists, who say corporate middlemen too often outweigh the judgment of clinicians closest to patients.

What happened: - West Cocoa Pharmacy & Compounding in Cocoa, Florida, recognized Donna Lowrey, RN, for testifying on Capitol Hill about the professional cost of speaking up for a hospitalized COVID-19 patient. - Lowrey spoke Monday, Sept. 28, at “COVID-19 Hospital Protocols: Real Stories from Real People,” a U.S. Senate roundtable convened by Sen. Ron Johnson, R-Wis., in the Kennedy Caucus Room of the Russell Senate Office Building. - Johnson’s office described the event as the first of his COVID-related events focused entirely on what happened inside hospitals. - Lowrey told the panel she was fired after advocating for a patient and recommending ivermectin, which the patient’s physician ordered. - The patient’s family said the patient declined after the drug was stopped, was placed on a ventilator and died. - Lowrey said, “I paid for that decision, but I would make it again.”

The details: - Lowrey has been a registered nurse since 1987. - She worked 31 years at the same community hospital in Titusville, Florida. - Dawn Butterfield, RPh, owner of West Cocoa Pharmacy & Compounding, said Lowrey showed courage by speaking up for a patient and family despite knowing the possible consequences. - Butterfield said independent pharmacists face similar pressure from pharmacy benefit managers, or PBMs, and other corporate middlemen. - Butterfield said those groups often override physicians’ and pharmacists’ judgment with profit-driven decisions. - Butterfield also said the people closest to the patient are often the last ones consulted in both hospital boardrooms and PBM formulary decisions. - The roundtable featured 21 patients, family members, doctors and nurses. - Sen. Johnson’s office is still collecting testimonies through the COVID Hospital Protocols survey at the Senate survey. - The full roundtable can be viewed through the link provided by Johnson’s office.

Between the lines: - The recognition is as much about healthcare politics as it is about one nurse’s experience. - West Cocoa Pharmacy & Compounding is using Lowrey’s story to argue that clinical judgment should stay with professionals at the bedside, not with administrators or intermediaries. - The testimony also suggests COVID-era hospital decisions remain a live issue for patients, families and clinicians.

What's next: - Johnson’s office will continue gathering accounts from people with COVID hospital protocol experiences. - Lowrey’s testimony is likely to keep circulating in debates over patient advocacy, hospital authority and pharmacy policy. - Florida independent pharmacists are expected to keep pressing their criticism of PBMs and other corporate decision-makers.